Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
HUTCHMED (China) Limited (GB:HCM)
LSE:HCM
RESEARCH TOOLSreports
HUTCHMED (China) Limited (HCM) Share Price & Analysis
2 Followers
HCM Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range130.00p - 337.46p
Previous Close277.5p
Volume80.13K
Average Volume (3M)61.07K
Market Cap
£2.44B
Enterprise ValueN/A
Total Cash (Recent Filing)$631.00M
Total Debt (Recent Filing)$23.30M
Price to Earnings (P/E)-91.7
Beta1.52
Next Earnings
Feb 29, 2024EPS Estimate
-£0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding864,775,340
10 Day Avg. Volume95,328
30 Day Avg. Volume61,070
Standard Deviation0.13
R-Squared0.06
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)4.73
Price to Sales (P/S)995.77
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
355.88pPrice Target Upside28.25% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
HUTCHMED (China) Limited News
HCM FAQ
What was HUTCHMED (China) Limited’s price range in the past 12 months?
HUTCHMED (China) Limited lowest share price was 130.00p and its highest was 337.46p in the past 12 months.
What is HUTCHMED (China) Limited’s market cap?
Currently, no data Available
When is HUTCHMED (China) Limited’s upcoming earnings report date?
HUTCHMED (China) Limited’s upcoming earnings report date is Feb 29, 2024 which is in 152 days.
How were HUTCHMED (China) Limited’s earnings last quarter?
HUTCHMED (China) Limited released its earnings results on Jul 31, 2023. The company reported 0.149p earnings per share for the quarter, beating the consensus estimate of -0.081p by 0.23p.
Is HUTCHMED (China) Limited overvalued?
According to Wall Street analysts HUTCHMED (China) Limited’s price is currently Undervalued.
Does HUTCHMED (China) Limited pay dividends?
HUTCHMED (China) Limited does not currently pay dividends.
What is HUTCHMED (China) Limited’s EPS estimate?
HUTCHMED (China) Limited’s EPS estimate is -£0.11.
How many shares outstanding does HUTCHMED (China) Limited have?
HUTCHMED (China) Limited has 870,991,460 shares outstanding.
What happened to HUTCHMED (China) Limited’s price movement after its last earnings report?
HUTCHMED (China) Limited reported an EPS of 0.149p in its last earnings report, beating expectations of -0.081p. Following the earnings report the stock price went down -2.829%.
Which hedge fund is a major shareholder of HUTCHMED (China) Limited?
Currently, no hedge funds are holding shares in GB:HCM
---
HUTCHMED (China) Limited Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
355.88p (28.25% Upside)
355.88p (28.25% Upside)
Insider Transactions
Sold Shares
Worth £36.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.16%
12-Months-Change
Fundamentals
Return on Equity
-5.01%
Trailing 12-Months
Asset Growth
3.78%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
HUTCHMED (China) Limited
Hutchison China Meditech is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Its reportable segments include the innovation platform and commercial platform. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The commercial platform includes a prescription drugs business and a consumer health business for over-the-counter drugs.
---
Top 5 ETFs holding HCM
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold HCM. The ETFs are listed according to market value of HCM within the ETF
---